Log in to save to my catalogue

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LO...

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LO...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03769509v1

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study

About this item

Full title

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study

Publisher

New York: Springer US

Journal title

Journal of neuro-oncology, 2020-06, Vol.148 (2), p.343-352

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Introduction
Primary Central Nervous System Lymphoma (PCNSL) is a rare disease with different therapeutic implications than systemic lymphoma. In this study, we evaluated whole-body
18
FDG-PET/CT for pre-chemotherapy imaging of suspected PCNSL.
Methods
One hundred and thirty consecutive immunocompetent patients were retrospectively i...

Alternative Titles

Full title

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03769509v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03769509v1

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-020-03525-5

How to access this item